Literature DB >> 9843180

Localization and translocation of MMP-2 during aggregation of human platelets.

G Sawicki1, E J Sanders, E Salas, M Wozniak, J Rodrigo, M W Radomski.   

Abstract

We have previously shown that human platelets express matrix metalloproteinase-2 (MMP-2) and that the release of this enzyme during platelet activation mediates the ADP- and thromboxane-independent part of aggregation. We have now used immunogold electron microscopy, flow cytometry. Western blot analysis and zymography methods to study the ultrastructural localization of MMP-2 in human washed platelets. Platelet aggregation was stimulated by collagen and the MMP-2 immunoreactivity of platelets was followed during various stages of aggregation. In resting platelets, MMP-2 was randomly distributed in the platelet cytosol without detectable association with platelet granules. Platelet aggregation caused the translocation of MMP-2 from the cytosol to the extracellular space. During the early stages of aggregation, MMP-2 remained in close association with the platelet plasma membrane. We conclude that the interactions of MMP-2 with platelet surface membranes mediate the aggregatory response induced by this enzyme.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843180

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  28 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.

Authors:  Anna Radomski; Paul Jurasz; Esmond J Sanders; Christopher M Overall; Heather F Bigg; Dylan R Edwards; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Nanoparticle-induced platelet aggregation and vascular thrombosis.

Authors:  Anna Radomski; Paul Jurasz; David Alonso-Escolano; Magdalena Drews; Maria Morandi; Tadeusz Malinski; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

4.  Protective action of doxycycline against diabetic cardiomyopathy in rats.

Authors:  N Yaras; M Sariahmetoglu; A Bilginoglu; A Aydemir-Koksoy; A Onay-Besikci; B Turan; R Schulz
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

5.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

6.  The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium.

Authors:  Thejaswi Kalagara; Tracy Moutsis; Yi Yang; Karin I Pappelbaum; Anne Farken; Lucia Cladder-Micus; Sabine Vidal-Y-Sy; Axel John; Alexander T Bauer; Bruno M Moerschbacher; Stefan W Schneider; Christian Gorzelanny
Journal:  Blood Adv       Date:  2018-09-25

7.  Pharmacological characteristics of solid-phase von Willebrand factor in human platelets.

Authors:  A Radomski; M W Stewart; P Jurasz; M W Radomski
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

8.  Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents.

Authors:  Brian Boylan; Michael C Berndt; Mark L Kahn; Peter J Newman
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

Review 9.  Role of cellular elements in thrombus formation and dissolution.

Authors:  N Wohner
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-07

10.  Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo.

Authors:  Stefania Momi; Emanuela Falcinelli; Silvia Giannini; Loredana Ruggeri; Luca Cecchetti; Teresa Corazzi; Claude Libert; Paolo Gresele
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.